Iovance Biotherapeutics Stock Price on December 31, 2023
| IOVA Stock | USD 12.36 0.14 1.12% |
Below is the normalized historical share price chart for Iovance Biotherapeutics extending back to September 01, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iovance Biotherapeutics stands at 12.36, as last reported on the 2nd of May, with the highest price reaching 12.36 and the lowest price hitting 12.36 during the day.
If you're considering investing in Iovance Stock, it is important to understand the factors that can impact its price. Iovance Biotherapeutics appears to be slightly risky, given 3 months investment horizon. Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. By evaluating Iovance Biotherapeutics' technical indicators, you can evaluate if the expected return of 0.91% is justified by implied risk. Please utilize Iovance Biotherapeutics' Downside Deviation of 3.86, risk adjusted performance of 0.0916, and Market Risk Adjusted Performance of 0.291 to validate if our risk estimates are consistent with your expectations.
At present, Iovance Biotherapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 246.9 M, whereas Common Stock Total Equity is forecasted to decline to 4,118. . As of May 2, 2024, Price To Sales Ratio is expected to decline to 1,286. In addition to that, Price Earnings Ratio is expected to decline to -4.52. Iovance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of October 2010 | 200 Day MA 8.2838 | 50 Day MA 14.0818 | Beta 0.587 |
Iovance |
Sharpe Ratio = 0.1348
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IOVA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.79 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.91 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Iovance Biotherapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iovance Biotherapeutics by adding it to a well-diversified portfolio.
Price Book 5.9028 | Enterprise Value Ebitda (7.60) | Price Sales 2.9 K | Shares Float 210.9 M | Wall Street Target Price 26 |
Iovance Biotherapeutics Valuation on December 31, 2023
It is possible to determine the worth of Iovance Biotherapeutics on a given historical date. On December 31, 2023 Iovance was worth 8.6 at the beginning of the trading date compared to the closed value of 8.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iovance Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Iovance Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iovance Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iovance Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.54 | 8.59 | 7.33 | 8.58 | 18,003,154 | |
12/29/2023 | 8.60 | 8.73 | 8.09 | 8.13 | 10,222,047 |
| 7.98 | 8.38 | 7.87 | 8.10 | 6,819,849 |
| Backtest Iovance Biotherapeutics | | | Iovance Biotherapeutics History | | | Iovance Biotherapeutics Valuation | Previous | Next |
Iovance Biotherapeutics Trading Date Momentum on December 31, 2023
| On January 02 2024 Iovance Biotherapeutics was traded for 8.10 at the closing time. The top price for the day was 8.38 and the lowest listed price was 7.87 . The trading volume for the day was 6.8 M. The trading history from January 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.37% . The trading delta at closing time against the current closing price is 3.08% . |
Iovance Biotherapeutics Fundamentals Correlations and Trends
By evaluating Iovance Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iovance Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iovance financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iovance Biotherapeutics Stock history
Iovance Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iovance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iovance Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iovance Biotherapeutics stock prices may prove useful in developing a viable investing in Iovance Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 235.1 M | 246.9 M | |
| Net Loss | -356.3 M | -338.5 M |
Iovance Biotherapeutics Quarterly Net Working Capital |
|
Iovance Biotherapeutics Stock Technical Analysis
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iovance Biotherapeutics Period Price Range
Low | December 29, 2023
| High |
8.60 | 8.13 |
Iovance Biotherapeutics May 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Iovance Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iovance Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Iovance Biotherapeutics stock market strength indicators, traders can identify Iovance Biotherapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 749383.0 | |||
| Daily Balance Of Power | (0.73) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 8.41 | |||
| Day Typical Price | 8.32 | |||
| Price Action Indicator | (0.51) | |||
| Period Momentum Indicator | 4.23 |
Iovance Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iovance Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Iovance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iovance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0916 | |||
| Jensen Alpha | 0.7077 | |||
| Total Risk Alpha | 0.3386 | |||
| Sortino Ratio | 0.2098 | |||
| Treynor Ratio | 0.281 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Iovance Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.89) | Revenue Per Share 0.005 | Return On Assets (0.40) | Return On Equity (0.82) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.